Literature DB >> 10222233

Prostaglandin J2 and its metabolites promote neurite outgrowth induced by nerve growth factor in PC12 cells.

T Satoh1, K Furuta, M Suzuki, Y Watanabe.   

Abstract

Although A- and J-type prostaglandins (PG's) arrest the cell cycle at the G1 phase in vitro and suppress tumor growth in vivo, their effects on neuronal cells have not so far been clarified. Here, we found promotion of neurite outgrowth as a novel biological function of PGJ's. In PC12h cells, PGJ's (PGJ2, Delta12-PGJ2 and 15-deoxy-Delta12,14-PGJ2) promoted neurite outgrowth in the presence of nerve growth factor (NGF), whereas they themselves did not show such a promotion. The potency of promoting neurite outgrowth was PGJ2 < Delta12-PGJ2 < 15-deoxy-Delta12,14-PGJ2. However, troglitazone, an activator of peroxisome proliferator-activated receptorgamma (PPARgamma), and other PG's including PGA1, PGA2 and PGD2 did not promote neurite outgrowth. These results suggest that PGJ's promote neurite outgrowth independently of PPARgamma activation. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10222233     DOI: 10.1006/bbrc.1999.0587

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

Review 1.  The NR4A nuclear receptor family in eosinophils.

Authors:  Ryoichi Hashida; Naganari Ohkura; Hirohisa Saito; Gozoh Tsujimoto
Journal:  J Hum Genet       Date:  2006-11-10       Impact factor: 3.172

2.  Differential effects of myocilin and optineurin, two glaucoma genes, on neurite outgrowth.

Authors:  Takahisa Koga; Xiang Shen; Jeong-Seok Park; Ye Qiu; Bum-Chan Park; Rajalekshmy Shyam; Beatrice Y J T Yue
Journal:  Am J Pathol       Date:  2009-12-03       Impact factor: 4.307

3.  A molecular mechanism for ibuprofen-mediated RhoA inhibition in neurons.

Authors:  John Dill; Ankur R Patel; Xiao-Li Yang; Robert Bachoo; Craig M Powell; Shuxin Li
Journal:  J Neurosci       Date:  2010-01-20       Impact factor: 6.167

4.  Agonism of Peroxisome Proliferator Receptor-Gamma may have Therapeutic Potential for Neuroinflammation and Parkinson's Disease.

Authors:  L Hunter Randy; Bing Guoying
Journal:  Curr Neuropharmacol       Date:  2007-03       Impact factor: 7.363

5.  Expression of E-FABP in PC12 cells increases neurite extension during differentiation: involvement of n-3 and n-6 fatty acids.

Authors:  Jo-Wen Liu; Frankis G Almaguel; Liming Bu; Daisy D De Leon; Marino De Leon
Journal:  J Neurochem       Date:  2008-05-30       Impact factor: 5.372

6.  Identification of a prostaglandin D2 metabolite as a neuritogenesis enhancer targeting the TRPV1 ion channel.

Authors:  Takahiro Shibata; Katsuhiro Takahashi; Yui Matsubara; Emi Inuzuka; Fumie Nakashima; Nobuaki Takahashi; Daisuke Kozai; Yasuo Mori; Koji Uchida
Journal:  Sci Rep       Date:  2016-02-16       Impact factor: 4.379

Review 7.  PPAR Gamma in Neuroblastoma: The Translational Perspectives of Hypoglycemic Drugs.

Authors:  Serena Vella; Pier Giulio Conaldi; Tullio Florio; Aldo Pagano
Journal:  PPAR Res       Date:  2016-10-05       Impact factor: 4.964

Review 8.  The therapeutic potential of CRTH2/DP2 beyond allergy and asthma.

Authors:  Katharina Jandl; Akos Heinemann
Journal:  Prostaglandins Other Lipid Mediat       Date:  2017-08-14       Impact factor: 3.072

9.  A plausible involvement of plasmalemmal voltage-dependent anion channel 1 in the neurotoxicity of 15-deoxy-Δ12,14 -prostaglandin J2.

Authors:  Hiromi Koma; Yasuhiro Yamamoto; Noboru Okamura; Tatsurou Yagami
Journal:  Brain Behav       Date:  2020-11-16       Impact factor: 2.708

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.